Truffle Capital
Europe, Ile-de-France, France, Paris
Description
Truffle Capital is an independent European private equity firm originally set up for investing in technology spin-offs.
Investor Profile
Truffle Capital has made 56 investments, with 1 in the past 12 months and 50% as lead.
Stage Focus
- Series A (29%)
- Series B (16%)
- Series Unknown (16%)
- Seed (11%)
- Undisclosed (9%)
- Post Ipo Equity (5%)
- Private Equity (5%)
- Series C (5%)
- Pre Seed (2%)
- Secondary Market (2%)
Country Focus
- France (71%)
- United States (5%)
- The Netherlands (5%)
- Switzerland (4%)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Belgium (4%)
- Morocco (2%)
'/%3e%3cpath d='m450 224.315-44.467 136.87 116.401-84.559h-143.87l116.403 84.559z' style='fill:none;stroke:%23006233;stroke-width:14.62993431;stroke-miterlimit:4;stroke-dasharray:none'/%3e%3c/svg%3e)
- Romania (2%)
- Estonia (2%)
- Austria (2%)
Industry Focus
- Biotechnology
- Financial Services
- Health Care
- Fintech
- Medical
- Software
- Information Technology
- Manufacturing
- Pharmaceutical
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
